06:42:39 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Cannvas Medtech Inc
Symbol MTEC
Shares Issued 45,424,461
Close 2019-02-13 C$ 0.265
Market Cap C$ 12,037,482
Recent Sedar Documents

Cannvas appoints Chasen to cannabis sciences board

2019-02-13 09:32 ET - News Release

Mr. Steve Loutskou reports

CANNVAS APPOINTS LEADING U.S.-BASED CANNABIS EDUCATOR TO ADVISORY BOARD

Cannvas Medtech Inc. has appointed a leading United States-based cannabis educator and industry consultant to its newly formed cannabis sciences advisory board. Emma Chasen will join the board to provide educational content focused on the science of cannabis, leveraging her academic training in plant chemistry and experience working with leading cannabis brands in developing educational programs for staff and customers.

"Emma brings an infectious energy and enthusiasm to the idea of cannabis education, along with a solid foundation of evidence-based knowledge and an unquenchable thirst to continue learning and sharing," said Steve Loutskou, chief operating officer of global markets at Cannvas. "We look forward to working with Emma and leaning on her expertise in cannabis sciences to continue providing our community with free and unbiased cannabis education from leading authorities in the field, going above and beyond the basics to allow Canadians access to a rich trove of information helping them make better decisions about their health and wellness."

Ms. Chasen has had formal academic training in studying plant chemistry and secondary compounds, terpenes, alkaloids and cannabinoids, earning a specialized biology degree with a focus on medicinal plant research from Brown University. During her time as director of education at award-winning Portland dispensary Farma, Ms. Chasen championed an evidence-based approach to cannabis education for consumers looking for alternative treatments, focusing on the plant's genetic and chemical makeup instead of standard binary classifications.

"The addition of Emma Chasen to our cannabis sciences advisory board emphasizes the attention we expect to be paid to the scientific aspects of cannabis, from identification to usage, as a growing body of research continues to accumulate," said Daniel Davidzon, director of strategy and education at Cannvas. "Emma's experience creating educational cannabis curricula is essential to offering Cannvas.Me users accurate and timely evidence-based information, positioning the platform to better adapt to new discoveries as the science of cannabis catches up to the rest of the industry."

Through her dedication to the science of cannabis, Ms. Chasen's work has been featured in Newsweek, Forbes, High Times Magazine, The Oregon Leaf, Teen Vogue and many more publications lauding her approach to cannabis education.

As co-owner and operator of Portland-based Eminent Consulting, Ms. Chasen oversees the creation and execution of educational training programs for cannabis industry professionals and enthusiasts. She has stated her mission in the cannabis industry is to educate people on the science of cannabis and provide them with accessible and meaningful information so they can feel empowered to take charge of their own health care experience.

The cannabis sciences advisory board is an independent panel of esteemed and established scientific consultants from across a range of industries providing oversight and original content to the Cannvas.Me digital cannabis education platform. Operating independent of any licensed producers or clinics, Cannvas.Me works with its medical advisory board, educational advisory panel and newly formed cannabis sciences advisory board to provide a safe space for cannabis education with no pressure to purchase or consume.

The cannabis sciences advisory board comprises prominent Canadians and Americans who are among the leaders in their fields with robust backgrounds in education, health sciences, medicine and research. Members of the board will be in constant communication with the Cannvas.Me team to offer guidance on new educational modules, oversight of and contributions to original Cannvas.Me content and insights into health sciences, clinical trials, medical and scientific regulatory affairs, and other related topics. Earlier this year, Cannvas appointed Angela Smith, doctor of philosophy, as the board lead.

About Cannvas Medtech Inc.

Cannvas is a leading digital cannabis education and business technology company within the health sciences space. The company designs and builds patient-centric platforms that enable its partners to harness the power of data to truly understand their customers.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.